Aclarion, Inc.

Aclarion, Inc. (ACON) priced its initial public offering on Apr 25, 2022 at $5.50 per share, within its $4.50–$6.50 range, raising $9.4M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $43M. Maxim Group was lead-left underwriter. Bingham & Associates advised the company and Ellenoff Grossman & Schole advised the underwriters.

Aclarion, Inc. is a healthcare technology company that uses Magnetic Resonance Spectroscopy and a proprietary biomarker to guide clinical treatment. Its technology targets the U.S. low back and neck pain market, and it uses AI for quality control of spectroscopy data.

Status

IPO

Ticker

ACON

Exchange

Nasdaq Capital Market

Priced

Apr 25, 2022

IPO price

$5.50

Price range

$4.50–$6.50

Raised

$9.4M

Market cap at IPO price

$43M

First filed

Jan 6, 2022

Underwriters

Maxim Group

Company counsel

Bingham & Associates

Underwriters' counsel

Ellenoff Grossman & Schole

Sector

Healthcare

Country / state

CO

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.